Skip to main content
The George Institute for Global HealthThe George Institute for Global Health
Covid-19 Covid 19 Covid 19
Donate

Social links Global

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
The George Institute for Global Health
  • About us
    • Our Mission And Values
    • Our Strategy
    • Our History
    • How Our Research Is Different
    • Our People
    • Board Of Directors
    • Global Advisory Committee (ACRIS)
    • Our Affiliates And Collaborators
    • George Health
    • Annual Reports
    • Financial Statements
    • Environmental Sustainability Commitment
  • Our Work
    • Our Priorities
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Ongoing Projects
    • Archived Projects
    • Publications
  • News & Events
    • Media Releases
    • News Stories
    • Media Coverage
    • Media Enquiries
    • Events
    • Past Events
    • Blogs / Profile Stories
    • E-Newsletters
    • Videos
    • Podcasts
  • Our Impact
    • Advocacy And Thought Leadership
    • Disruptive Social Entrepreneurship
    • Policy statements and recommendations
    • Case Studies And Examples
    • 20 Years Of Impact
    • Careers & studies
      • The George Experience
      • Current Job Opportunities
    • Contact Us
    • Get involved
      • Giving Opportunities
      • Building Back Better After COVID-19: The Research Agenda
      • Reclaiming Comprehensive Public Health: A Call to Action
      • Join Us Register
      • Clinical Trials

      Donate

    • Donate
    1. Home
    2. Publications

    The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: The TASCS randomised controlled trial

    Authors
    N Berend
    Type of Publication
    Journal Article
    Year of Publication
    2021
    Journal
    European Respiratory Journal
    Language
    Eng
    Links to full text
    • Google Scholar
    • BibTeX
    • EndNote X3 XML
    • EndNote 7 XML
    • Endnote tagged
    • Marc
    • RIS
    Search Publications

    Latest Publications

    • Developing ethical standards for dissemination and implementation research: a roadmap for consensus and guidance

      Implementation Science Communications

      2023

    • Antioxidants for adults with chronic kidney disease

      Cochrane Database of Systematic Reviews

      2023

    • Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes

      Medicine

      2023

    • Kidney Function, Albuminuria and Risk of Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis.

      Am J Kidney Dis

      2023

    View all
    • About us
    • Our Work
    • News & Events
    • Our Impact
    • Careers & studies
    • Get involved
    • Thought leadership
    • Contact us
    • Donate

    The George Institute for Global Health

    Level 18, International Towers 3, 300 Barangaroo Ave
    Barangaroo NSW 2000 Australia
    Tel: +61 2 8052 4300
    Fax: +61 2 8052 4301
    info@georgeinstitute.org

    The George Institute country sites:

    • The George Institute country sites:
    • Australia
    • China
    • India
    • UK
    • Affiliated with UNSW Sydney
    • In partnership with Imperial College London
    • In partnership with Manipal Academy of Higher Education

    Social links Global

    • Facebook
    • LinkedIn
    • Twitter
    • YouTube

    Subscribe to our E-newsletter

    Acknowledgement of Country

    The George Institute acknowledges the Gadigal People of the Eora Nation as the Traditional Custodians of the land on which our Australia office and Global Headquarters are built. We pay our respect to Elders past, present and emerging.

    Copyright © 2023 The George Institute

    Footer Links

    • Disclaimer
    • Privacy policy
    • Data sharing policy
    • Whistleblower policy
    • Modern slavery statement
    • Research code policy
    • PHS awards financial COI policy
    • Sitemap